⌘K

Login Start Free

Home/Filings/4/0001209191-15-060935

4//SEC Filing

AMICUS THERAPEUTICS INC 4

Accession 0001209191-15-060935

$FOLDCIK 0001178879operating

View on SEC.gov Company Profile

Filed

Jul 14, 8:00 PM ET

Accepted

Jul 15, 5:05 PM ET

Size

19.2 KB

Accession

0001209191-15-060935

Insider Transaction Report

Form 4

Period: 2015-07-13

AMICUS THERAPEUTICS INCFOLD

VP, Pharmacology & Biology

Transactions

Exercise/Conversion
Common stock
2015-07-13$15.00/sh+3,000$45,000→ 30,687 total
Sale
Common stock
2015-07-13$15.00/sh−3,000$45,000→ 27,687 total
Exercise/Conversion
Stock Options (right to buy)
2015-07-13−9,500→ 0 total
Exercise: $5.33From: 2010-02-01Exp: 2016-02-28→ Common Stock (9,500 underlying)
Sale
Common stock
2015-07-13$15.00/sh−2,500$37,500→ 27,687 total
Exercise/Conversion
Stock Options (right to buy)
2015-07-13−3,000→ 24,000 total
Exercise: $4.38From: 2016-06-01Exp: 2022-06-04→ Common Stock (3,000 underlying)
Sale
Common stock
2015-07-13$15.00/sh−9,500$142,500→ 27,687 total
Exercise/Conversion
Common stock
2015-07-13$15.00/sh+2,500$37,500→ 30,187 total
Exercise/Conversion
Common stock
2015-07-13$15.00/sh+9,500$142,500→ 37,187 total
Exercise/Conversion
Stock Options (right to buy)
2015-07-13−2,500→ 20,000 total
Exercise: $4.16From: 2013-11-01Exp: 2019-11-16→ Common Stock (2,500 underlying)

Footnotes (1)

[F1]The exercise of stock options and subsequent sale of common stock were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 21, 2015.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

AMICUS THERAPEUTICS INC

CIK 0001178879

Entity typeoperating

IncorporatedDE

Related Parties

1

filerCIK 0001178879

Filing Metadata

Form type: 4
Filed: Jul 14, 8:00 PM ET
Accepted: Jul 15, 5:05 PM ET
Size: 19.2 KB

View on SEC.gov